Neisseria meningitidis
Showing 1 - 25 of 263
Gonorrhea Male Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)
Recruiting
- Gonorrhea Male
- Cefixime
- +6 more
-
Chapel Hill, North CarolinaClinical and Translational Research Center (CTRC) at University
May 19, 2022
Assess Oropharyngeal Carriage of N. Meningitidis in South
Completed
- Neisseria Meningitidis
-
Adelaide, South Australia, AustraliaWomen's and Children's Hosptial
Oct 10, 2021
Neisseria Gonorrhoeae Infection Trial in Chapel Hill (Meningococcal Group B Vaccine)
Completed
- Neisseria Gonorrhoeae Infection
- Meningococcal Group B Vaccine
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care
Jun 24, 2021
Meningococcal Vaccines, Meningococcal Infections, Neisseria Meningitidis Trial in Oxford (4CMenB (Bexsero®) - Novartis Vaccines
Completed
- Meningococcal Vaccines
- +3 more
- 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Oct 26, 2021
Meningococcal B Disease Trial in Worldwide (rLP2086 vaccine, Pediatric HAV vaccine)
Completed
- Meningococcal B Disease
- rLP2086 vaccine
- Pediatric HAV vaccine
-
Canberra, Garran, Australian Capital Territory, Australia
- +24 more
Aug 30, 2021
Hiv, Meningococcal Infections, Pneumococcal Infections Trial in Hvidovre (Neisseria meningitidis oligosaccharide conjugate
Recruiting
- Hiv
- +2 more
- Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
-
Hvidovre, DenmarkHvidovre Hospital
May 5, 2021
MENINGOCOCCAL INFECTION Trial in Finland, Poland (Bivalent rLP2086 Vaccine, Licensed pediatric hepatits A vaccine, Normal
Completed
- MENINGOCOCCAL INFECTION
- Bivalent rLP2086 Vaccine
- +2 more
-
Espoo, Finland
- +14 more
Oct 22, 2020
Haemophilus Influenzae Type b, Neisseria Meningitidis, Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine Trial in
Completed
- Haemophilus Influenzae Type b
- +2 more
- Menitorix
- Infanrix IPV
-
Bydgoszcz, Poland
- +8 more
Jun 2, 2020
Meningococcal Invasive Infections at Participating Centers
Recruiting
- Invasive Meningococcal Disease
- surveillance
-
Calgary, Alberta, Canada
- +12 more
Apr 4, 2022
Petechiae In Children Study: Defining A Clinical Decision Rule
Completed
- Meningitis, Meningococcal
- +5 more
-
Belfast, Northern Ireland, United KingdomRoyal Belfast Hospital for Sick Children
Dec 10, 2019
Whole Cell Pertussis, Tetanus, Hepatitis B Trial in Muntinlupa, Bangkok (Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix,
Completed
- Whole Cell Pertussis
- +5 more
- Tritanrix-HepB/Hib-MenAC
- +2 more
-
Muntinlupa, Philippines
- +1 more
Feb 17, 2020
Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)
Not yet recruiting
- Meningitis, Meningococcal
- rMenB+OMV NZ
-
Anyang-Si, Gyeonggi-do, Korea, Republic of
- +6 more
Oct 27, 2023
Whole Cell Pertussis, Haemophilus Influenzae Type b, Hepatitis B Trial in Bangkok, Khon Kaen, Songkla (Tritanrix-HepB/Hib-MenAC,
Completed
- Whole Cell Pertussis
- +5 more
- Tritanrix-HepB/Hib-MenAC
- +3 more
-
Bangkok, Thailand
- +2 more
Feb 17, 2020
Meningococcal Vaccine Trial in United States (MenABCWY, Saline)
Active, not recruiting
- Meningococcal Vaccine
- MenABCWY
- Saline
-
Mobile, Alabama
- +19 more
Feb 15, 2022
A Prospective, Non-interventional, Observational Study of
Not yet recruiting
- Atypical Hemolytic Uremic Syndrome(aHUS)
- (no location specified)
Oct 23, 2023
Infections, Meningococcal Trial in Worldwide (Meningococcal vaccine GSK134612, Prevenar 13™)
Completed
- Infections, Meningococcal
- Meningococcal vaccine GSK134612
- Prevenar 13™
-
Garran, Australian Capital Territory, Australia
- +50 more
Sep 7, 2021
Splenectomy; Status Trial (Bexsero)
Not yet recruiting
- Splenectomy; Status
- Bexsero
- (no location specified)
Aug 29, 2023
Meningococcal Disease, Invasive Trial in Calgary, Vancouver, Halifax (MenACWY-CRM, MenACWY-DT, MenACWY-TT)
Completed
- Meningococcal Disease, Invasive
- MenACWY-CRM
- +2 more
-
Calgary, Alberta, Canada
- +2 more
Mar 10, 2022
Meningitis Trial in Bamako (NmCV-5, MenACWY-TT)
Recruiting
- Meningitis
- NmCV-5
- MenACWY-TT
-
Bamako, MaliCentre pour le Developpement des Vaccins du Mali
Mar 29, 2022
Preventive Immunization; Meningitis Trial in Boston (Menactra)
Active, not recruiting
- Preventive Immunization; Meningitis
- Menactra
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 14, 2022
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)
Not yet recruiting
- Pneumococcal Vaccines
- 12-Valent Pneumococcal Conjugate Vaccine
- (no location specified)
Jan 31, 2023
Preeclampsia, Severe Preeclampsia, Eculizumab Trial in Los Angeles (Eculizumab)
Suspended
- Preeclampsia
- +11 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 16, 2022
Meningitis, Meningococcal Trial in Worldwide (MenABCWY vaccine, Placebo, MenACWY vaccine)
Active, not recruiting
- Meningitis, Meningococcal
- MenABCWY vaccine
- +3 more
-
Houston, Texas
- +3 more
Jun 1, 2022